About Event
Welcome to the Glioblastoma Drug Development Summit
Devised with three crucial and bold intentions, the 3rd Annual Glioblastoma Drug Development Summit is the ONLY meeting to:
- Overcome the key biological obstacles constraining successful glioblastoma therapies
- Assess innovative treatments and pioneering trial design to avoid further unfortunate phase 2 failures
- Bring together key stockholders within the GBM drug development field with the common aim of bringing-to-market safe, efficient & deliverable treatments to patients-in-need
Who Attended in 2022?
Sneak peak of crucial topics we addressed:
- Investment and financing for biopharma in glioblastoma drug development
- Role of Immunotherapy for Treatment of Glioblastoma
- Empowering the Immune System to Treat Glioblastoma: DNA as Medicine
- Surgical Immunotherapy Trials Using Genes and Viruses for GBM
- Externally Controlled Trials: Using External Data to Design Efficient Clinical Trials in Glioblastoma